- Home
- FENG vs FGEN Comparison
FENG vs FGEN Comparison
Compare FENG & FGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FENG
- FGEN
- Stock Information
- Founded
- FENG 1998
- FGEN 1993
- Country
- FENG China
- FGEN United States
- Employees
- FENG N/A
- FGEN N/A
- Industry
- FENG Broadcasting
- FGEN Biotechnology: Pharmaceutical Preparations
- Sector
- FENG Industrials
- FGEN Health Care
- Exchange
- FENG Nasdaq
- FGEN Nasdaq
- Market Cap
- FENG 37.6M
- FGEN 34.0M
- IPO Year
- FENG 2011
- FGEN 2014
- Fundamental
- Price
- FENG $2.43
- FGEN $0.36
- Analyst Decision
- FENG
- FGEN
- Analyst Count
- FENG 0
- FGEN 0
- Target Price
- FENG N/A
- FGEN N/A
- AVG Volume (30 Days)
- FENG 5.8K
- FGEN 1.5M
- Earning Date
- FENG 11-12-2024
- FGEN 11-12-2024
- Dividend Yield
- FENG N/A
- FGEN N/A
- EPS Growth
- FENG N/A
- FGEN N/A
- EPS
- FENG N/A
- FGEN N/A
- Revenue
- FENG $99,426,474.00
- FGEN $180,015,000.00
- Revenue This Year
- FENG N/A
- FGEN $20.42
- Revenue Next Year
- FENG N/A
- FGEN N/A
- P/E Ratio
- FENG N/A
- FGEN N/A
- Revenue Growth
- FENG N/A
- FGEN 16.15
- 52 Week Low
- FENG $1.20
- FGEN $0.18
- 52 Week High
- FENG $4.15
- FGEN $2.93
- Technical
- Relative Strength Index (RSI)
- FENG 41.29
- FGEN 50.21
- Support Level
- FENG $2.41
- FGEN $0.18
- Resistance Level
- FENG $2.98
- FGEN $0.43
- Average True Range (ATR)
- FENG 0.18
- FGEN 0.04
- MACD
- FENG -0.03
- FGEN 0.01
- Stochastic Oscillator
- FENG 19.67
- FGEN 66.94
About FENG Phoenix New Media Limited
Phoenix New Media Ltd is a media company providing premium content on an integrated platform across the internet, mobile and TV channels in China. The company organizes its operations into two main segments: Net advertising services and Paid services. It provides its content and services through three channels: ifeng.com channel, video channel, and mobile channel. The company also offers a wide range of paid services including mobile value-added services, games, and content sales. It generates the majority of its revenue from Net advertising services. Geographically, it derives revenue from China.
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The Company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.